EHC vs the Top Picks average
| Pillar | EHC | Book avg | Diff |
|---|---|---|---|
| Quality | 0.68 | 0.83 | -0.15 |
| Growth | 0.73 | 0.87 | -0.13 |
| Value | 0.63 | 0.76 | -0.13 |
Averaged across the 30 names in today's Top Picks (mean score 81.5). A name can beat these averages and still be absent from the book — it also applies concentration limits.
One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.
EHC at a glance
Every figure here comes from the same audited fundamentals behind the score. Charts drawn from data the score does not use say so on the card.
Analyst estimate revisions
| 30-day change | +2.2% |
|---|---|
| 90-day change | +2.1% |
| Forward EPS estimate | $6.68 |
Over the last 90 days, what analysts expect EHC to earn is drifting higher (+2.1%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.
A rising estimate means expectations are improving, not that the price has failed to keep up — and estimates get cut as readily as they get raised. It is not part of the Bull Rankings score. Biggest movers across the market →
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.
Encompass Health Corporation (EHC): score, valuation & FAQ
Encompass Health Corporation (EHC) is a Medical Care Facilities company that scores 68.1 out of 100 on the Bull Rankings quality-growth model — a solid, above-average reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.
Its strongest graded signals are PEG (A) and P/E (A-). On valuation, EHC sits about 16% above our discounted-cash-flow fair value — the current price implies roughly 10% annual free-cash-flow growth over the next decade.
Is EHC a good stock to buy?
Bull Rankings scores EHC 68.1 out of 100 on its quality-growth model, which is a solid, above-average reading. That is driven by PEG (A) and P/E (A-). A score is a quantitative screen of Encompass Health Corporation's fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
Why does EHC score 68.1 on Bull Rankings?
The score leans on growth at 73.5 out of 100, with value the weakest pillar at 63.1 — the three combine geometrically, so a weak one cannot be papered over by a strong one. EHC earns its highest marks on PEG (A) and P/E (A-). Each signal is graded against sector-aware thresholds rather than one absolute bar, so EHC is measured against Medical Care Facilities peers, not against the market as a whole.
Is EHC overvalued or undervalued?
Based on $120.14, EHC sits about 16% above our discounted-cash-flow fair value — the current price implies roughly 10% annual free-cash-flow growth over the next decade. It trades at a 20.1x P/E (graded A-). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.
What are the main risks of investing in EHC?
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.
Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial advisor.